Former Eli Lilly and Sanofi exec to establish pain killer empire
Danish researcher Philip Just Larsen has conducted diabetes research for companies like Novo Nordisk, Sanofi and Eli Lilly. Now, he is CSO in German Grünenthal and aims to develop the future's pain killers and maybe even find a solution to the deadly opioid addiction.
When Philip Just Larsen took position as CSO in German pharmaceutical company Grünenthal it also marked the end of more than 20 years long career in diabetes research.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
